Elena Rybakina to withdraw from US Open 2026? – Left heel, World No. 1 ranking, and a fateful decision

Cincinnati, Ohio – With the score at 1-4 in the first set against Iga Swiatek, Elena Rybakina walked off the court. Not because of a failed forehand or a lost service game. She could not move. That was the moment an entire hard-court summer – and possibly her World No. 1 ambitions – hung by a thread of heel tendon. The context of this story is not just an injury. Rybakina faces a simple but brutal arithmetic: reach the US Open 2026 semi-final to confirm the World No. 1 ranking. Seven matches at a Grand Slam. A massive workload even when fully healthy. With a left heel tendon issue – per ESPN sources – this is no longer a tactical problem, but a question of physical endurance. What concerns me here is not whether she plays or not. It is the data gap this injury creates. When a player retires at 1-4 in the first set, there is almost no in-match evidence to assess whether her service rhythm, return position, or footwork were still functional. We do not know if her powerful serve – her greatest weapon – remains intact when pushing off the left heel. This is a data blind spot ahead of a Grand Slam. From an analytical perspective, I see three key signals. First, this injury is not about stroke technique, but about movement. On hard courts, where stopping, pushing off, and lateral sliding are foundational, a player who cannot move cannot hide weaknesses with serving or first-strike tactics. Second, the decision to try to play one more service game before retiring – as the article describes – shows competitive courage, but also potentially unnecessary risk tolerance. The article does not state whether medical staff cleared her to continue, but a player who cannot move her leg should normally stop immediately. Third, the ranking objective makes a deep run mandatory, not optional. If the tendon issue limits her in later rounds, tactical planning will matter less than physical capacity. What I want to question here is a common assumption: that a top, Grand Slam-experienced player knows how to protect herself. But tennis history is full of examples of top players competing with injuries and making things worse. The question is not whether Rybakina is brave enough to play, but whether she is wise enough to withdraw when necessary. Withdrawing from mixed doubles signals she is prioritizing singles, but it also shows her body is sending warning signals. Based on my experience following matches, I notice something: players with aggressive games built on explosive footwork struggle most when returning from lower-leg injuries. Not because they cannot hit the ball, but because they lose the confidence to move instinctively. The psychological fear of re-injury is often harder to fix than the physical damage. If Rybakina enters the US Open with hesitation in every step, she will be at a disadvantage not just physically, but mentally against fresh opponents. The real story here is not whether she withdraws. It is how she – and her team – handle a decision that no data can answer for them. My statistical models can predict semi-final probabilities based on form, but they cannot measure pain levels or re-injury risk. This is where data becomes powerless, and experience, self-honesty, and medical advice become decisive factors. If she plays, I will watch one specific metric: first-serve points won in the opening games of each set. If this number drops from her average, it will signal the serve is under pressure from the heel. If she withdraws, it will be a difficult but possibly the wisest decision for her long-term career. Either way, US Open 2026 will be a test not just of technique or tactics, but of the ability to make the right decision under pressure – a skill no statistics table can measure. Cincinnati gave us a glimpse of the limits of Rybakina's body. The US Open will tell us whether she can push past those limits. And perhaps most importantly, we will learn whether she is wise enough to know when to stop.